In tests using animals, drug successfully seeks and disarms toxic clumps of proteins responsible for Alzheimer’s and Parkinson’s
An international team of more than 18 research groups has demonstrated that the compounds they developed can safely prevent harmful protein aggregation in preliminary tests using animals. The findings raise hope that a new class of drugs may be on the horizon for the more than 30 diseases and conditions that involve protein aggregation, including diabetes, cancer, spinal cord injury, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Proteins are necessary for almost every cellular process. However, when cell machinery doesn’t clear out old proteins, they can clump, or aggregate, into toxic plaques that lead to disease.
“Diseases caused by protein aggregation affect millions of people around the world,” said Gal Bitan, Ph.D., associate professor of neurology at the David Geffen School of Medicine at the University of California – Los Angeles, who will present the team’s latest work at the American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting during Experimental Biology 2015. “We hope that the new compounds will provide therapy for diseases caused by protein aggregation, many of which have no treatment at all.”
The researchers call the compounds that they developed molecular tweezers because of the way they wrap around the lysine amino acid chains that make up most proteins. The compounds are unique in their ability to attack only aggregated proteins, leaving healthy proteins alone.
To develop a new drug, researchers typically screen large libraries of compounds to find ones that affect a protein involved in a disease. Bitan’s team used a fundamentally different approach to develop the molecular tweezers.
“We looked at the molecular and atomic interactions of proteins to understand what leads to their abnormal clumping,” Bitan said. “Then, we developed a tailored solution. So unlike many other drugs, we understand how and why our drug works.”
The team is in the process of testing multiple versions of the tweezers, each with a slightly different molecular makeup. For CLR01, one of the most promising versions, the researchers have demonstrated therapeutic benefits in two rodent models of Alzheimer’s disease, two fish and one mouse model of Parkinson’s disease, a fish model of spinal cord injury and a mouse model of familial amyloidotic polyneuropathy, a rare disease in which protein aggregation affects the nervous system, heart and kidneys.
“Our data suggest that CLR01, or a derivative thereof, may become a drug for a number of diseases that involve protein aggregation,” Bitan said. “We also found a high safety window for CLR01.”
In one of the safety tests, mice receiving a daily CLR01 dose 250 times higher than the therapeutic dose for one month showed no behavioral or physiological signs of distress or damage. In fact, blood cholesterol in the mice dropped by 40 percent, a possible positive side effect of CLR01.
The Latest on: Molecular tweezers
via Google News
The Latest on: Molecular tweezers
- Fungal communities decline with urbanization—more in air than in soilon August 5, 2020 at 6:21 am
Here we show that both aerial and soil fungal communities are greatly poorer in urban than in natural areas. Strikingly, a fivefold reduction in fungal DNA abundance took place in both air and soil ...
- Inspired by chameleons, scientists use liquid crystals to create color-changing materialson July 31, 2020 at 9:52 am
Inspired by this, scientists at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have developed a way to stretch and strain liquid crystals to generate different colors.
- Meet the surface chemist supporting the molecular electronics revolutionon July 22, 2020 at 5:00 pm
Wenning was relocating to start a new role at Roswell Biotechnologies, a life-sciences start-up that is developing molecular electronic chips to read and sequence DNA. The firm’s goal is to sequence ...
- Mystery of the missing moleculeson July 22, 2020 at 8:56 am
It started last December, when she and her team constructed a new apparatus capable of achieving the lowest-temperature chemical reactions of any currently available technology, and then broke and ...
- Max Planck Institute of Molecular Cell Biology and Geneticson July 21, 2020 at 5:00 pm
How do cells form tissues? How do tissues form organisms? Cell and developmental biologists at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden devote their research to ...
- SRRF 'n' TIRF - simultaneous spatiotemporal super-resolution and multi-parametric fluorescence microscopyon July 16, 2020 at 1:00 am
He completed his diploma thesis in physics at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, where he worked on the influence of light polarization on the forces in optical ...
- A nanomaterial path forward for COVID-19 vaccine developmenton July 15, 2020 at 2:15 am
(Nanowerk News) From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging ...
- Joshua Alperon December 3, 2018 at 7:49 pm
The coordinated action of molecular motor proteins is critical to multiple aspects ... We make experimental measurements with high-resolution techniques, including optical tweezers and light ...
- Physics researchon October 4, 2018 at 5:27 am
We employ and develop methods to explore the thermodynamical properties of atomic and molecular systems. In order to study the associated high-dimensional phase space we employ and develop methods ...
- Xiaohui Qu: Overviewon September 27, 2018 at 7:05 pm
My lab conducts high-resolution, single-molecule studies of the molecular mechanisms of ribosome functions ... Figure 1 — Example application of optical tweezers to study translational control. In ...
via Bing News